CP
Christine A Poon
Director

Christine A Poon insider trades: Regeneron Pharmaceuticals (REGN) stock buys and sales

Director, Regeneron Pharmaceuticals Last trade Nov 2, 2026 213 Form 4 filings
$7.6M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2008
7
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Christine reports to the SEC

and 1 more company

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 2, 2026REGN↓ Sell$7.6M
Oct 29, 2025REGN↓ Sell$4.3M
Aug 15, 2024REGN↓ Sell$12.6M
Aug 23, 2023REGN↓ Sell$10.3M
Aug 9, 2022REGN↓ Sell$9.3M
Aug 27, 2021REGN↓ Sell$10.0M
Aug 28, 2020REGN↓ Sell$24.0M
Aug 12, 2015REGN↓ Sell$63K
Nov 25, 2014REGN↑ Buy$164K
May 21, 2014REGN↑ Buy$74K
May 14, 2008PRU↑ Buy$100K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other REGN insiders

Open-market trades in the last 12 months

About Christine A Poon's insider trades

Christine A Poon is a director at Regeneron Pharmaceuticals (REGN). Since May 14, 2008, Christine has reported 3 open-market purchases worth $339K and 8 sales worth $78.2M on SEC Form 4. In the last 12 months: 1 sale ($7.6M).

Their filings also include grants and awards (183 filings), option exercises (25 filings), other transactions (15 filings), shares returned to the company (10 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every REGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.